Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2011 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Presents Clinical Data of Catena® in Duchenne Muscular Dystrophy at the 2011 Congress of the World Muscle Society

Liestal, Switzerland, October 19, 2011 - Santhera Pharmaceuticals (SIX: SANN) announced today that it will present data from the 2-year open-label study (DELPHI-E study) evaluating Catena® for the...
October 19, 2011 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Presents Clinical Data of Catena® in Duchenne Muscular Dystrophy at the 2011 Congress of the World Muscle Society

Liestal, Switzerland, October 19, 2011 - Santhera Pharmaceuticals (SIX: SANN) announced today that it will present data from the 2-year open-label study (DELPHI-E study) evaluating Catena® for the...
September 12, 2011 11:35 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera to Present at Biotech in Europe Investor Forum

Liestal, Switzerland, September 12, 2011 - Santhera Pharmaceuticals (SIX: SANN) today announced that Klaus Schollmeier, Chief Executive Officer, will sit on an expert panel on Public Markets &...
September 12, 2011 11:35 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera to Present at Biotech in Europe Investor Forum

Liestal, Switzerland, September 12, 2011 - Santhera Pharmaceuticals (SIX: SANN) today announced that Klaus Schollmeier, Chief Executive Officer, will sit on an expert panel on Public Markets &...
August 29, 2011 14:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera veröffentlicht Halbjahreszahlen 2011 und kündigt Re-strukturierungspläne zur strategischen Fokussierung auf Catena® an

Liestal, Schweiz, 29. August 2011 - Santhera Pharmaceuticals (SIX: SANN) gibt heute die finanziellen Resultate für das 1. Halbjahr 2011 sowie Pläne zur Restrukturierung des Unternehmens bekannt....
August 29, 2011 14:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Announces Interim Financial Results for the First Half Year of 2011 and Restructuring Plans to Concentrate on Catena® Franchise

Liestal, Switzerland, August 29, 2011 - Santhera Pharmaceuticals (SIX: SANN) announced today the financial results for the first half of 2011 and plans for a restructuring. In the first six months of...
August 24, 2011 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera erhält Patent in den USA für Catena® zur Behandlung von Muskeldystrophien

Liestal, Schweiz, 24. August 2011 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass die US-amerikanische Patent- und Markenbehörde den Patentschutz für Idebenone (Markenname...
August 24, 2011 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Obtains US Patent for Use of Catena® in the Treatment of Muscular Dystrophies

Liestal, Switzerland, August 24, 2011 - Santhera Pharmaceuticals (SIX: SANN) announced today that the United States Patent and Trademark Office granted patent protection for the use of idebenone...
August 23, 2011 01:05 ET | Source: Santhera Pharmaceuticals Holding AG

Disclosure of shareholdings in accordance with articles 20 and 21 SESTA

Disclosure of shareholdings in accordance with articles 20 and 21 SESTA Liestal, Switzerland, August 23, 2011 - Santhera Pharmaceuticals (SWX: SANN) was informed by Baker Bros. Advisors, LLC, 667...
August 23, 2011 01:05 ET | Source: Santhera Pharmaceuticals Holding AG

Disclosure of shareholdings in accordance with articles 20 and 21 SESTA

Liestal, Switzerland, August 23, 2011 - Santhera Pharmaceuticals (SWX: SANN) was informed by Baker Bros. Advisors, LLC, 667 Madison Avenue, New York, NY 10065, USA, that - Baker Brothers Life...